Interestingly, it was shown that inhibition of CHIT1 has more favorable therapeutic effects than nintedanib and comparable therapeutic efficiency to pirfenidone in the bleomycin-induced pulmonary fibrosis model (24, 67). This evidence concerns the gene CHIT1 and pulmonary fibrosis.